Skip to main content
Clinical Trials/NCT05969665
NCT05969665
Recruiting
Not Applicable

Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors After Cardiac Rehabilitation - A Randomised Controlled Trial: MITIGATE-RF

University Hospital, Basel, Switzerland1 site in 1 country100 target enrollmentFebruary 7, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Heart Disease
Sponsor
University Hospital, Basel, Switzerland
Enrollment
100
Locations
1
Primary Endpoint
Change in cardiovascular risk factor score HbA1c
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The study aims to assess the effect of smart watches and continuous glucose measuring devices on cardiovascular risk factors.

Detailed Description

Within a period of 4 months 100 patients will be recruited and randomised to the intervention or control arm (1:1) for a duration of 3 months. Randomisation will be stratified by age, sex, BMI, diabetes, blood pressure, and duration after finishing cardiac rehabilitation. Patients randomised to the intervention arm will be given a smart watch as well as a continuous blood glucose measurement device with detailed instructions. At baseline and at the end of the study questionnaires will be answered and anthropomorphic measurements attained. Blood samples will be drawn at baseline and after an intervention period of 3 months in all subjects. Additional data on sleep, temperature, heart rate (resting and exercise), breathing rate, activity and exercise, oxygen saturation and daily weight will be collected through the Fitbit web application programming interface (API).

Registry
clinicaltrials.gov
Start Date
February 7, 2024
End Date
August 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed Consent signed by the subject
  • Completed outpatient cardiac rehabilitation
  • Diagnosis of coronary heart disease
  • Access to a smartphone for the duration of the study
  • 18 years or older on the date of consent

Exclusion Criteria

  • Diseases which limit physical activity including angina with incomplete revascularisation, arrhythmogenic cardiomyopathy, stroke with residual disease, and major orthopaedic disorders
  • Known or suspected non-compliance
  • Inability to follow the procedures of the investigation, e.g., due to language problems, psychological disorders, dementia, etc. of the subject
  • Diabetic patients receiving insulin therapy
  • Lack of proficiency with smart phone/watch
  • Current participation in any other clinical trial, which may confound the results of this trial.
  • NYHA (New York Heart Association) class III or IV congestive heart failure
  • Pregnancy

Outcomes

Primary Outcomes

Change in cardiovascular risk factor score HbA1c

Time Frame: at baseline and after 3 month

For the risk factor HbA1c 0 to 2 points will be awarded. 2 points will be rewarded if the patient reaches the goals according to ESC-Guidelines where applicable, 1 point if the patient reaches the goal partially and 0 if the patient does not reach the goal. Goals according to ESC Guidelines: DM (diabetes mellitus) HbA1c \< 7.0% or \< 6.5% in recent diagnosis No DM \< 5.7% (cut-off prediabetes) Points according to goals: 2 = \< 5.7 % 1 = 5.7 - 6.5 % 0 = \> 6.5 %

Change in cardiovascular risk factor score blood pressure

Time Frame: at baseline and after 3 month

For the risk factor blood pressure 0 to 2 points will be awarded. 2 points will be rewarded if the patient reaches the goals according to ESC (European Society of Cardiology) -Guidelines where applicable, 1 point if the patient reaches the goal partially and 0 if the patient does not reach the goal. Goals according to ESC Guidelines: Systolic 120-130 mmHg (18-69y.) Systolic \< 140 mmHg (70y.) Diastolic \< 80 mmHg (all ages) Points according to goals: 2 = age related SBP (systolic blood pressure) \& DBP (diastolic blood pressure) goals 1 = \< 140 mmHg, \> 130 mmHg 18-69yr. or \< 140 mmHg and \> 90 mmHg DBP \>70yr 0 = SBP \> 140 mmHg

Change in cardiovascular risk factor score LDL

Time Frame: at baseline and after 3 month

For the risk factor LDL 0 to 2 points will be awarded. 2 points will be rewarded if the patient reaches the goals according to ESC-Guidelines where applicable, 1 point if the patient reaches the goal partially and 0 if the patient does not reach the goal. Goals according to ESC Guidelines: LDL \<1.4 mmol/l and 50% reduction from baseline Points according to goals: 2 = \< 1.4 mmol/l 1 = \< 1.8 mmol/l 0 = \> 1.8 mmol/l

Change in cardiovascular risk factor score BMI

Time Frame: at baseline and after 3 month

For the risk factor BMI 0 to 2 points will be awarded. 2 points will be rewarded if the patient reaches the goals according to ESC-Guidelines where applicable, 1 point if the patient reaches the goal partially and 0 if the patient does not reach the goal. Goals according to ESC Guidelines: BMI 20-25 kg/m2 AC (Abdominal circumference) \< 102 (men) \< 88 (women) WHR (waist to hip ratio) 0.75-0.9 men \& 0.70-0.85 women Points according to goals: 2 = BMI and AC in range 1 = only BMI or AC in range 0 = nothing in range

Change in cardiovascular risk factor score smoking

Time Frame: at baseline and after 3 month

For the risk factor smoking 0 or 3 points will be awarded. Points according to goals: Smoking (yes/no) 3 = no 0 = yes

Change in cardiovascular risk factor score physical activity

Time Frame: at baseline and after 3 month

For the risk factor physical activity 0 to 2 points will be awarded. 2 points will be rewarded if the patient reaches the goals according to ESC-Guidelines where applicable, 1 point if the patient reaches the goal partially and 0 if the patient does not reach the goal. Goals according to ESC Guidelines: \> 150min/week moderate PA (mPA), better 300min/week (self-reported) or \> 75min/week vigorous PA (vPA), better 150min/week (self-reported) Points according to goals: 2 = \> 300 min. mPA or \> 150 min. vPA 1 = \> 150 min. mPA or \> 75 min. vPA 0 = \< 150 min. mPA or \< 75 min. vPA Or mix or mPA and vPA respectively

Change in cardiovascular risk factor score nutrition

Time Frame: at baseline and after 3 month

For the risk factor nutrition 0 to 2 points will be awarded. 2 points will be rewarded if the patient reaches the goals according to ESC-Guidelines where applicable, 1 point if the patient reaches the goal partially and 0 if the patient does not reach the goal. Goals according to ESC Guidelines: ≥ 5 portions fruit/vegetables a day Unsalted nuts ≥ 3x/week Reduction in saturated fats Points according to goals: 2 = 5/day OR 4/day + nuts 3x/week + reduction in saturated fats 1 = 4/day OR 3/day + nuts 3x/week + reduction in saturated fats 0 = \< 4/day

Study Sites (1)

Loading locations...

Similar Trials